story of the week
Long-Term Outcomes of Treatment With Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
N. Engl. J. Med 2024 Sep 15;[EPub Ahead of Print], JD Wolchok, V Chiarion-Sileni, P Rutkowski, CL Cowey, D Schadendorf, J Wagstaff, P Queirolo, R Dummer, MO Butler, AG Hill, MA Postow, C Gaudy-Marqueste, T Medina, CD Lao, J Walker, I Márquez-Rodas, JBAG Haanen, M Guidoboni, M Maio, P Schöffski, MS Carlino, S Sandhu, C Lebbé, PA Ascierto, GV Long, C Ritchings, A Nassar, M Askelson, MP Benito, W Wang, FS Hodi, J LarkinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.